http://www.redorbit.com/news/health...-for-diabetes-cholesterol-approved/index.html
“Perhaps one third of the nation’s eligible patients with type 2 diabetes are not being treated with a statin, so here’s a convenient tool for doctors to target glucose as well as cholesterol levels,” Dr. Sethu Reddy, Merck’s director of clinical affairs for diabetes, told the AP.
Am really not sure of the efficacy of this nor the ethics. 8)
“Perhaps one third of the nation’s eligible patients with type 2 diabetes are not being treated with a statin, so here’s a convenient tool for doctors to target glucose as well as cholesterol levels,” Dr. Sethu Reddy, Merck’s director of clinical affairs for diabetes, told the AP.
Am really not sure of the efficacy of this nor the ethics. 8)
